Open Access Repository

Item Statistical Overview

All items > Item: Cost-effectiveness of domestic PD-1 inhibitor Camrelizumab combined with chemotherapy in the first-line treatment of advanced nonsquamous non–small-cell lung cancer in China
Downloads
Activity Overview
5Downloads
7Hits
TOP